Panavir gel for local and external use 30g

Description

Composition Active ingredient: 100 g of the preparation contains: Panavir ® (potato extract shoots) – 0.002 g ;. Excipients: Glycerol – 30.00 g, macrogol 4000 – 15.00 g, Macrogol 400 – 38.00 g of ethanol 95% – 1.00 g sodium hydroxide – 0.40 g of lanthanum nitrate hexahydrate – 2.20 g, water – up to 100.00 g Description: The homogeneous mass of white color with a weak specific smell. Product form: Gel for external and local application of 0.002%. 3 g, 5 g, 10 g or 30 g in a tube of aluminum with an internal lacquer coating. 1 tube together with instructions for use in a stack of cardboard. Contraindications Individual intolerance and hypersensitivity to the drug. Children up to age 18 years. Dosage 0.2 mg / g Indications infectious-inflammatory diseases of the skin and / or mucous membranes, caused by the herpes simplex virus Herpes simplex types I and II (including genital herpes). HPV infection of the skin and / or mucous membranes of the genital and perianal region, in combination with laser destruction of genital warts. Interactions with other drugs have been reported. Overdose Cases of overdose are not logged in. Preclinical studies indicate low toxicity. The drugs group: antiviral agent of vegetable origin. Pharmacodynamics: Panavir ® – a purified extract of the plant shoots of Solanum tuberosum; the main active substance – hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids. Preparation Panavir ® has viralstatic action. It is active against herpes simplex virus Herpes simplex types I and II. Inhibits replication and virus polymerase reactions by blocking viral DNA synthesis in the affected cells of the skin and / or mucous membranes. Tests showed no mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic action. In preclinical studies in laboratory animals, adverse effects on reproduction and fetal development has not been established. Pharmacokinetics: The pharmacokinetics of the formulation was not studied drug. Pregnancy and lactation Use during pregnancy is possible only when the intended benefits to the mother outweighs the potential risk to the fetus. If necessary, use during lactation breastfeeding at the time of taking the medication should be discontinued. Conditions of supply of pharmacies without a prescription. Adverse events Occurrence of quickly passing redness and itching of the skin and / or mucous membranes at the site of application of the gel. If you notice any other side effects not mentioned in the instructions, tell your doctor. Specific guidance is recommended to begin treatment in the early stage of the disease is possible, at the first sign (itching, tingling, flushing, feelings of tension), in this case the bubble development stage of the disease can be completely prevented. Panavir ® herpes drug is not intended for ophthalmic use. When the gel is applied on the face to avoid contact with eyes. Effects on ability to drive a vehicle, These mechanisms on the possibility of a negative effect of the drug on the ability to drive vehicles and the implementation of potentially hazardous activities that require attention and psychomotor speed reactions, no. Storage conditions in a dry, dark place at a temperature of from 2 to 25 ° C. Keep out of the reach of children. Dosing and dose Outwardly and topically. Gel (ointment for herpes) depositing a thin layer to the affected areas of the skin and / or mucous membranes 5 times per day. For the treatment of infectious and inflammatory diseases of the skin and / or mucous membranes caused by the herpes simplex virus Herpes simplex types I and II (including genital herpes) – 5 times a day for 4-5 days. The treatment may be extended to 10 days. For the treatment of papillomavirus infections – 2 times a day for 5 days before and 10 days after laser degradation warts. Info appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist